SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-12-006032
Filing Date
2012-11-13
Accepted
2012-11-13 10:03:10
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q0912_yewbio.htm 10-Q 1372370
2 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER f10q0912ex31i_yewbio.htm EX-31.1 10017
3 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER f10q0912ex31ii_yewbio.htm EX-31.2 10133
4 CERTIFICATION OF PERIODIC FINANCIAL REPORT BY THE CHIEF EXECUTIVE OFFICER AND CH f10q0912ex32_yewbio.htm EX-32 5581
  Complete submission text file 0001213900-12-006032.txt   7993294

Data Files

Seq Description Document Type Size
5 yewb-20120930.xml EX-101.INS 1299414
6 yewb-20120930.xsd EX-101.SCH 72722
7 yewb-20120930_cal.xml EX-101.CAL 50077
8 yewb-20120930_def.xml EX-101.DEF 133217
9 yewb-20120930_lab.xml EX-101.LAB 448488
10 yewb-20120930_pre.xml EX-101.PRE 316527
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 121196458
SIC: 0100 Agricultural Production-Crops